Jean-Yves Blay
Directeur/Membre du Conseil chez INNATE PHARMA
Fortune : 118 $ au 30/04/2024
Profil
Jean-Yves Blay is currently an Independent Director at Transgene SA since 2022, the General Director at Centre Léon Bérard Lyon et Rhône-Alpes since 2014, and an Independent Member-Supervisory Board at Innate Pharma SA since 2017.
Previously, he served as the President of the European Organisation for Research & Treatment of Cancer from 2009 to 2012 and as the President of UNICANCER from 2019 to 2022.
He also held the position of Secretary-Oncology Commission at Académie Nationale de Médecine FCP.
Dr. Blay obtained his doctorate degree from Université Claude Bernard Lyon 1 in 1994.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
INNATE PHARMA SA CLASS A
0,00% | 31/12/2022 | 50 ( 0,00% ) | 118 $ | 30/04/2024 |
Postes actifs de Jean-Yves Blay
| Sociétés | Poste | Début |
|---|---|---|
| INNATE PHARMA | Directeur/Membre du Conseil | 13/12/2017 |
| TRANSGENE | Directeur/Membre du Conseil | 25/05/2022 |
| Centre Léon Bérard Lyon et Rhône-Alpes | Directeur Général | 01/01/2014 |
Anciens postes connus de Jean-Yves Blay
| Sociétés | Poste | Fin |
|---|---|---|
UNICANCER
 UNICANCER Hospital/Nursing ManagementHealth Services UNICANCER is a French hospital network that is dedicated to fighting against cancer. The private company is based in Paris, France. It is the only national hospital federation that is solely focused on oncology. The network comprises of 18 French cancer centers (CLCC) and a private non-profit health establishment. The CLCCs take care of almost 530,000 patients annually. UNICANCER is also a leading academic promoter of clinical trials in oncology in Europe, with 106 active clinical trials promoted and nearly 7,600 patients included. | President | 01/01/2022 |
| European Organisation for Research & Treatment of Cancer | President | 01/01/2012 |
| Académie Nationale de Médecine FCP | Corporate Officer/Principal | - |
Formation de Jean-Yves Blay
| Université Claude Bernard Lyon 1 | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| INNATE PHARMA | Health Technology |
| TRANSGENE | Health Technology |
| Entreprise privées | 4 |
|---|---|
| Centre Léon Bérard Lyon et Rhône-Alpes | |
| Académie Nationale de Médecine FCP | Commercial Services |
| European Organisation for Research & Treatment of Cancer | |
UNICANCER
UNICANCER Hospital/Nursing ManagementHealth Services UNICANCER is a French hospital network that is dedicated to fighting against cancer. The private company is based in Paris, France. It is the only national hospital federation that is solely focused on oncology. The network comprises of 18 French cancer centers (CLCC) and a private non-profit health establishment. The CLCCs take care of almost 530,000 patients annually. UNICANCER is also a leading academic promoter of clinical trials in oncology in Europe, with 106 active clinical trials promoted and nearly 7,600 patients included. | Health Services |
